IDiyas

For the Inventor, By the Inventor

Arlington Heights, IL, United States of America

Robert J Chorvat

USPTO Granted Patents = 23

Average Co-Inventor Count = 1.6

ph-index = 4

Forward Citations = 58(Granted Patents)


Location History:

  • Lake Bluff, IL (US) (1987 - 1988)
  • Arlington Heights, IL (US) (1976 - 1992)

Company Filing History:

goldMedal22 out of 1,323 
 
G.d. Searle & Company
 patents
silverMedal1 out of 1 
 
D. G. Searle & Co.
 patent

Years Active: 1976-1992

Loading Chart...
23 patents (USPTO):Explore Patents
1. 5097035 - Monobasic disobutamide derivatives (1992-03-17),
2. 4791199 - Process for antiarrhythmic 1,3-diazabicyclo[4.4.0]dec-2-en-4-ones (1988-12-13),
3. 4704382 - Phenylpiperazine phosphonates (1987-11-03),
4. 4680295 - Octahydropyrido[1,2-c]pyrimidinones and (1987-07-14),
5. 4639524 - Monobasic disobutamide derivatives (1987-01-27),
6. 4567270 - Hexahydroindolizinones useful for treating cardiac arrhythmia, (1986-01-28),
7. 4560754 - Substituted 5-phenyl-5-(aminoalkyl)-1,3-diazabicyclo[4.4.0]decan-4-ones (1985-12-24),
8. 4554353 - 2,5-Pyrrolidinedione derivatives useful as antiarrhythmic agents (1985-11-19),
9. 4500708 - Benzothiazine derivatives (1985-02-19),
10. 4399279 - 4H-1,4-Benzothiazine derivatives and intermediates thereto (1983-08-16),
11. 4356302 - 4H-1,4-Benzothiazine derivatives (1982-10-26),
12. 4348328 - 25-Substituted-5.alpha.-cholestane-3.beta.,22S-diol (1982-09-07),
13. 4329295 - 24-Cyclopropylcholene-3.beta., 22-diols and esters thereof (1982-05-11),
14. 4299774 - 25-Alkylcholest-5-ene-3 .beta.,22-diols and esters thereof (1981-11-10),
15. 4230626 - 25-Halocholest-5-ene-3.beta.,22-diols and esters thereof (1980-10-28),

Title: **An Insight into the Innovations of Robert J. Chorvat**

Introduction

Robert J. Chorvat is a notable inventor based in Arlington Heights, IL, recognized for his contributions to pharmaceutical sciences and innovation. With a remarkable catalog of 23 patents to his name, Chorvat’s work primarily centers around antiarrhythmic compounds and their applications.

Latest Patents

Chorvat's latest patents showcase his expertise in developing pharmaceutical compositions. One significant patent concerns monobasic disobutamide derivatives, which involve complex compounds with various substituent groups. These compounds are particularly noted for their utility as antiarrhythmic agents. Another patent details a process for preparing antiarrhythmic 1,3-diazabicyclo[4.4.0]dec-2-en-4-ones, which are derived from specific amides. This innovative process involves the use of 1-acyl-.alpha.-[2-[bis(1-methylethyl)amino]ethyl]-.alpha.-phenyl-2-piperid ineacetamides that serve as effective intermediates.

Career Highlights

Throughout his distinguished career, Robert J. Chorvat has worked with several prominent companies, including G.D. Searle & Company and D.G. Searle & Co. His involvement in these organizations has allowed him to contribute significantly to the fields of chemistry and pharmaceuticals, paving the way for breakthroughs in treatment methodologies.

Collaborations

Chorvat has collaborated with esteemed colleagues such as Bipinchandra N. Desai and Raphael Pappo, fostering an environment of innovation and creativity. These partnerships have not only enhanced the development of groundbreaking products but also enriched Chorvat's own research endeavors.

Conclusion

Robert J. Chorvat's commitment to innovation and excellence is evident through his extensive patent portfolio and collaborations. His contributions to the field of antiarrhythmic agents continue to have a profound impact on pharmaceutical sciences, heralding advancements that improve patient care and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…